Rhythm Pharmaceuticals, Inc. (XETR:1RV) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Edward Mathers Other companies: NeueHealth Inc (Director · Since at least Oct 2, 2025); MBX Biosciences, Inc. (Director · Since at least Sep 12, 2024); Senti Biosciences Holdings, Inc. (Director · Since at least Jun 8, 2022); OnKure Therapeutics, Inc. (Director · Since at least Apr 8, 2021); Trevi Therapeutics, Inc. (Director · Since at least May 7, 2019); Inozyme Pharma Inc (Director · Jul 23, 2020 – Jun 18, 2024 · Past); Akouos Inc (Director · Jun 25, 2020 – Dec 1, 2022 · Past); Mirum Pharmaceuticals, Inc. (Director · Jul 17, 2019 – Jun 2, 2022 · Past); Ra Pharmaceuticals Inc (Director · Jun 28, 2018 – Apr 2, 2020 · Past); Synlogic Inc (Director · Dec 29, 2017 – Jun 22, 2023 · Past) | Director · Since at least Oct 4, 2017 |
| Kimberly Popovits Other companies: Kardigan, Inc. (Director · Since at least Jun 17, 2026); EXACT Sciences Corporation (Director · Since at least Jan 2, 2025); 10x Genomics, Inc. (Director · Since at least Mar 26, 2020); Kiniksa Pharmaceuticals International, plc (Director · Since at least May 23, 2018); Talis Biomedical Corp (Director · Feb 11, 2021 – Jun 9, 2023 · Past); MyoKardia Inc (Director · Mar 15, 2017 – Nov 17, 2020 · Past); Genomic Health Inc (President and CEO, Director · Nov 3, 2016 – Nov 8, 2019 · Past) | Director · Since at least Apr 1, 2026 |
| David Meeker Other companies: Kardigan, Inc. (Board of Directors · Since at least Jun 17, 2026); Pharvaris N.V. (Chair of the Board · Since at least Mar 18, 2026); Trevi Therapeutics, Inc. (Chairman · Since at least May 7, 2019); Turmeric Acquisition Corp (Director · Oct 15, 2020 – Oct 15, 2020 · Past); MyoKardia Inc (Director · Apr 17, 2017 – Nov 17, 2020 · Past); Savient Pharmaceuticals Inc (Director · Jan 7, 2013 – Jan 7, 2013 · Past) | Chairman, President, and Chief Executive Officer · Since at least Oct 4, 2017 |
| David McGirr Other companies: X4 Pharmaceuticals, Inc. (Director · Since at least Nov 15, 2017); Insmed Incorporated (Director · Since at least Oct 30, 2013); Roka Bioscience Inc (Director · Jul 16, 2014 – Jun 28, 2017 · Past); Relypsa Inc (Director · Nov 14, 2013 – Sep 1, 2016 · Past); Cubist Pharmaceuticals Inc (SVP & Chief Financial Officer · Mar 31, 2010 – Feb 15, 2013 · Past) | Director · Since at least Oct 4, 2017 |
| Neil Exter Other companies: Maze Therapeutics, Inc. (Director · Since at least Jan 30, 2025); Decibel Therapeutics Inc (Director · Feb 11, 2021 – Jun 17, 2022 · Past); Pliant Therapeutics, Inc. (Director · Jun 2, 2020 – Jun 16, 2022 · Past); Revolution Medicines, Inc. (Director · Feb 12, 2020 – Jun 16, 2022 · Past); CytomX Therapeutics, Inc. (Director · Oct 7, 2015 – Jun 20, 2017 · Past) | Director · Oct 4, 2017 – Jun 6, 2018 · Past |
| Stuart Arbuckle Other companies: Praxis Precision Medicines, Inc. (Director · Since at least Jan 8, 2026); Alnylam Pharmaceuticals, Inc. (Director · Since at least Jan 5, 2026); Vertex Pharmaceuticals Incorporated (EVP, COO · Since at least May 25, 2016); ImmunoGen Inc (Director · Jan 23, 2018 – Feb 12, 2024 · Past); Dare Bioscience, Inc. (Director · Jun 22, 2016 – Jan 3, 2017 · Past) | Director · Since at least Jul 23, 2019 |
| Jonathan Silverstein Other companies: Arcutis Biotherapeutics, Inc. (Director · Jan 30, 2020 – Oct 2, 2020 · Past); Adicet Bio, Inc. (Director · Jan 25, 2018 – Jun 3, 2020 · Past); Glaukos Corporation (Director · Dec 13, 2017 – Mar 2, 2018 · Past); Scpharmaceuticals Inc (Director · Nov 16, 2017 – Nov 21, 2017 · Past) | Director · Oct 4, 2017 – Oct 4, 2017 · Past |
| Jennifer Good Other companies: Trevi Therapeutics, Inc. (President and Chief Executive Officer · Since at least May 7, 2019); Juniper Pharmaceuticals Inc (Director · Sep 7, 2017 – Aug 14, 2018 · Past); Penwest Pharmaceuticals Co (President & CEO · Apr 28, 2010 – Nov 4, 2010 · Past) | Director · Since at least Jun 19, 2019 |
| Keith Gottesdiener Other companies: Septerna, Inc. (Director · Since at least Sep 25, 2025); Prime Medicine, Inc. (See Remarks, Director · Oct 19, 2022 – May 8, 2025 · Past); Intercept Pharmaceuticals Inc (Director · Jul 19, 2016 – Nov 8, 2023 · Past) | CEO & President, Director · Oct 4, 2017 – Mar 9, 2020 · Past |
| Lynn A. Tetrault Other companies: Alumis Inc. (Director · Since at least May 21, 2025); NeoGenomics, Inc. (Director · Since at least Jun 2, 2021); Acelyrin, Inc. (Director · Dec 18, 2023 – May 21, 2025 · Past) | Director · Since at least Dec 9, 2020 |
| Camille L. Bedrosian Other companies: Crinetics Pharmaceuticals, Inc. (Director · Since at least Jun 11, 2025); Amylyx Pharmaceuticals, Inc. (Chief Medical Officer · Since at least Mar 31, 2025) | Director · Since at least Jun 18, 2025 |
| Hunter Smith Other companies: Spyre Therapeutics, Inc. (Director · Nov 12, 2021 – Jun 22, 2023 · Past); Genesee & Wyoming Inc (Director · Jun 30, 2015 – Dec 30, 2019 · Past) | Chief Financial Officer and Treasurer · Since at least Oct 4, 2017 |
| Manher Joshi Other companies: Soleno Therapeutics, Inc. (Chief Development Officer · Since at least Nov 10, 2025); Atara Biotherapeutics, Inc. (EVP, Chief Medical Officer · Jun 1, 2023 – Nov 16, 2023 · Past) | Chief Medical Officer · Since at least Aug 17, 2026 |
| Fred T Fiedorek Other companies: Verve Therapeutics Inc (Chief Medical Officer · Sep 18, 2023 – Feb 14, 2024 · Past) | Chief Medical Officer · Oct 4, 2017 – Feb 14, 2018 · Past |
| Jennifer Chien Other companies: Krystal Biotech, Inc. (Chief Commercial Officer · Jan 20, 2020 – Jan 31, 2020 · Past) | EVP, Head of North America · Since at least Nov 9, 2020 |
| Alastair Garfield | Chief Scientific Officer · Since at least Jul 1, 2025 |
| Alicia Fiscus | Chief Regulatory Officer · Since at least Nov 5, 2026 |
| Christophe R. Jean | Director · Since at least Jun 18, 2025 |
| Christopher Paul German | Corporate Controller & CAO · Since at least Aug 11, 2023 |
| Elisabeth Crönert-Bendell | Senior Vice President, Head of Strategy · Since at least Nov 5, 2026 |
| Jennifer Lee | Executive Vice President, Head of North America · Since at least Aug 14, 2026 |
| Jim Flaherty | Senior Vice President and General Counsel · Since at least Nov 5, 2026 |
| Joe Shulman | Chief Technical Officer · Since at least Jul 9, 2025 |
| Yann Mazabraud | EVP, Head of International · Since at least Oct 5, 2020 |